Therapeutic Area | MeSH |
---|---|
signs and symptoms pathological conditions | D013568 |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
HYCODAN | Genus Lifesciences | N-005213 RX | 1988-07-26 | 2 products, RLD |
Brand Name | Status | Last Update |
---|---|---|
homatropine hydrobromide ophthalmic | unapproved drug other | 2022-10-28 |
hycodan | New Drug Application | 2021-12-29 |
hydrocodone bitartrate and homatropine methylbromide | ANDA | 2024-10-08 |
hydrocodone bitartrate and homatropine methylbromide syrup | ANDA | 2009-09-21 |
hydromet | ANDA | 2024-05-31 |
Drug common name | Homatropine |
INN | homatropine methylbromide |
Description | Homatropine (Equipin, Isopto Homatropine) is an anticholinergic medication that is an antagonist at muscarinic acetylcholine receptors and thus the parasympathetic nervous system. It is used in eye drops as a cycloplegic (to temporarily paralyze accommodation), and as a mydriatic (to dilate the pupil).
|
Classification | Small molecule |
Drug class | atropine derivatives |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)C(O)c1ccccc1)C2 |
PDB | — |
CAS-ID | 87-00-3 |
RxCUI | — |
ChEMBL ID | CHEMBL1618018 |
ChEBI ID | 5747 |
PubChem CID | 6321423 |
DrugBank | DB00725 |
UNII ID | 68JRS2HC1C (ChemIDplus, GSRS) |